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Abstract 
Evaluating the Effective Peak Capacity of a Saw-Tooth Gradient for 
Reverse-Phase High Performance Liquid Chromatography Separation of 




The performance of saw-tooth gradient for comprehensive proteome analysis is evaluated 
using model proteins and a low molecular weight human serum by reverse-phase high 
performance liquid chromatography.  The peak splitting and number of peptides detected 
is used to characterize the effective peak capacity of the saw-tooth gradient as a function 
of solvent strength change (Δφ).  Peak splitting demonstrated in experimental result as 
one single peptide or protein detected in more than one saw-tooth step.  No peak splitting 
is observed directly from chromatograms for two model proteins by decreasing the 
solvent strength change (Δφ) from 5.0%, 1.0%, to 0.1%.  The numerical comparisons of 
the peak area, peak width and peak asymmetry from saw-tooth gradients with the same 
parameter from the linear gradient show no peak splitting for both model proteins.  
Anthracene does not have peak splitting, but a significant reduction in peak area is 
observed.  It is indicated that the S values proportional with the molecular weight 
significantly affect the observed effective peak capacities.  Peak capacity of the saw-tooth 
gradient is also explored by a LMW (≤30kDa) human serum on an online capillary-
HPLC-ESI-FTICR MS by decreasing the Δφ from 1.0%, 0.5%, 0.2%, to 0.1% in the 
26.0%-27.0% solvent B range.  When the Δφ decreases from 0.5% to 0.1%, the number 
of protein splitting increases from 5 to 28 while a higher increase in the number of total 
peptide signals detected is observed from 21 to 67 when Δφ decreases from 1.0% to 
0.1%.  In fact, more peptide signals are observed with the saw-tooth gradient than the 
long linear gradient.  Moreover, no new proteins are detected in the isocratic holding 
segment.  Overall, the saw-tooth gradient provides a promising first dimension separation 
technique for a two-dimension separation with an effective peak capacity of several 
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1.1 Research purposes and goals 
Many biological or environmental samples are extremely complex and cannot be 
separated adequately, creating a need for the development of improved separations.  
Recently we reported the development of a saw-tooth gradient that is well suited for use 
prior to the final stage of a multi-dimensional separation.1  The overall utility of this 
method is largely dependent on the effective peak capacity that can be achieved.  
Although the concept of peak capacity easily translates to all separations, the gradient 
alternates between negative and positive slopes, making it discontinuous in nature.  Thus, 
an operational approach has been used to evaluate the effective peak capacity for this 
saw-tooth gradient.  For the comprehensive proteomic analyses, detection limits and 
sample throughput are the main consideration because the detection of low abundance 
proteins is the main concern.  Much current research is focused on improving the 
detection of low abundance proteins and increasing the total number of proteins that can 
be identified in comprehensive proteome analyses.  The purpose of this work is to 
determine the extent to which the solvent strength change of each gradient step can be 
reduced while minimizing peak splitting and maximizing the number of proteins 
identified.  The peak capacity is evaluated by two model proteins to explore the optimum 
solvent strength change that has minimum peak splitting.  The peak splitting on a small 
molecular weight compound is evaluated to provide supporting information for the peak 
splitting results on peptides and proteins.  The accuracy of the saw-tooth gradient 
delivery by the produced with the capillary high performance liquid chromatography 
system interfaced with the MS is evaluated.  The protein recovery rate of the nonporous 
beads packed column is also compared with porous beads packed columns.  Finally, the 
maximum peak capacity of the saw-tooth gradient with minimum peak splitting is further 
evaluated using a real proteomic sample.  The total protein and peak splitting numbers 
are used to justify which saw-tooth gradient has the maximum peak capacity and 
minimum peak splitting.  The protein loss in the isocratic segment of the saw-tooth 
gradient is also evaluated by comparing the spectrum with adjacent spectra eluted by 
saw-tooth steps.  The results of the saw-tooth gradient are compared with the 
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corresponding linear gradient to provide thorough understanding of the properties of the 
saw-tooth gradient. 
1.2 Separation in Proteomics 
Proteomics is the high throughput protein analysis from biological system, which 
emphasizes identification and quantitation of as many components as possible.2  Proteins 
are responsible for almost all processes occurring in an organism, and their abundance 
and structure are likely to change as a response to disease.  Protein complexes are 
important in signal transduction, metabolism and protein synthesis.  A proteome is very 
complex and changes with the cell type and cell history.3  Proteomics will help us 
understand the fundamental biology of cells and living systems.  This knowledge is very 
important for finding biomarkers for diseases and determining the underlying changes in 
molecular biological that lead to diseased states in order to rationally design new 
treatments.  
Serum is an excellent example of a real proteomic sample which has a high 
content of proteins (60-80 mg of protein/mL), with many of these being secreted and 
shed from cells and tissues.  However, the majority of the serum proteins are composed 
by six abundant proteins (representing approximately 85% of the total protein mass): 
albumin, IgG, IgA, transferrin, haptoglobin and alpha-1-antitrypsin.4  While most 
clinically important proteins (~10,000 proteins) have low abundance and have 
concentrations of 10 orders of magnitude less than the more abundant serum proteins.5-8  
This large dynamic range of proteins makes the detection of low molecular weight 
protein analysis extraordinarily challenging by any separation technique.  The most 
powerful one dimensional column chromatography techniques typically have a peak 
capacity of a few hundred, where peak capacity is defined as the maximum number of 
peaks that can be resolved on a given column.9  However, the actual number of 
completely resolved components is always much smaller than the theoretical peak 
capacity.  Peak capacity assumes perfect spacing of all the separated components.  In the 
real world with proteins, spacing is random.  This discrepancy between the limited 
capabilities of one dimensional separations and the complexity of real world samples 
motivates the development of multidimensional separations, due to the greatly enhanced 
resolving power they offer.10 
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Since the dynamic range of the serum sample is large, it is important to reduce the 
sample complexity by removing the most abundant proteins using current methods.  The 
low abundance proteins cannot be observed without removal of high abundance proteins.  
It is difficult to detect lower abundance proteins without effectively removing higher 
abundance proteins.  Affinity chromatography7 and ultrafiltration11 are two broadly used 
techniques to remove the more abundant proteins in serum.   
1.3 Multi-dimensional Separation Techniques 
1.3.1 Fundamentals and advantages 
After depletion of abundant proteins, a separation technique, such as ion 
exchange5, 8, 12, reverse-phase liquid chromatography,7, 13 and/or isoelectric focusing14-16, 
can be used as fractionation technique to further reduce the sample into small groups.  
Then another technique that is orthogonal to the fractionation technique can be used to 
separate the proteins in each fraction for identification. 
A multi-dimensional separation combines two or more modes of separation to 
complete a single analysis.  The benefits of the multi-dimensional separations include 
increased peak capacity, which is the product of peak capacity of each individual 
separation dimension.  Multi-dimensional separation allows an increased number of 
components to be detected from complex mixtures.  The fundamental requirements of 
multi-dimensional separations were first established by Giddings.17  First, all the 
separation mechanisms must be orthogonal, which means that the separation mechanisms 
of all the modes used must be different from each other.  If not orthogonal, the total peak 
capacity will be less than the product of the peak capacity of each technique.  If the 
separation modes are orthogonal, the distribution of the components in one dimension 
does not correlate with the distribution of components in another dimension.  Second, any 
recombination of peaks separated in the first dimension at the beginning of the second 
dimension decreases the overall peak capacity.  Because the peak capacity is the product 
of the peak capacity of each dimension, adding additional dimensions can increase the 
peak capacity.  However, there have been few reports of multi-dimensional separations 
with more than two dimensions of separation due to the practical constraints.10  
When performing two-dimensional separations, the sampling rate of the second-
dimension separation with respect to the elution speed of the first dimension defines the 
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extent to which the separation achieved in the first dimension is preserved in the second 
dimension.  Higher sampling rates improve the resolving power and peak capacity of the 
first dimension.  It is suggested that each peak in the first dimension should be sampled at 
least three times to obtain high two-dimensional resolution.18  However, higher sampling 
rates also divide the sample into more fractions, which reduces the S/N and increases the 
limits of detection for interfaces that combine complete transfer of sample between the 
first and second dimensions.  For comprehensive proteomic analyses, detection limits and 
sample throughput are the main consideration because the detection of low abundance 
proteins is the main concern.   
1.3.2 Development of two-dimensional (2D) techniques for peptides and proteins 
Multi-dimensional separation techniques for biomolecules such as peptides and 
proteins can be generally summarized into four categories: 2D-gel electrophoresis, LC-
LC and LC-CE.  2D gel electrophoresis is a 2D-in-parallel separation technique which 
separates the analytes over a two-dimensional planar surface.  All the others are typically 
2D-in-series, in which the separation is carried out by first performing a one-dimension 
separation, and then sequentially subjecting individual fractions to a second-dimensional 
separation.10, 19 
Two-dimensional gel electrophoresis (2DE) is used routinely for proteome 
analysis.  In 2DE, the first dimension is isoelectric focusing (IEF) which separates the 
analytes by their pI value and the second dimension is sodium dodecyl sulfate 
polyacrylamide gel sieving electrophoresis (SDS-PAGE) which separates by molecular 
weight. These two methods are orthogonal to each other.  However, it has many 
limitations.  First, the detection of low abundance proteins is restricted by the limited 
peak capacity and high limit of detections.  In proteomics, many proteins that are 
potential biomarkers are low abundant.  Second, the separation of membrane proteins 
remains challenging because their solubility can not be maintained in the gel.  Membrane 
proteins play a central role in many biological activities.  Third, the method is labor 
intensive, requires high skill level, and is difficult to automate.10, 20   
 The limitations of 2D-gel can be reduced by 2D separation methods based on 
liquid chromatography (LC) and/or capillary electrophoresis (CE).  Since LC and CE 
include many different separation modes, many biomolecules that are difficult to separate 
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by 2D-gel such as hydrophobic, acidic, and basic proteins can be separated by choosing 
proper modes.  Additionally, LC and CE techniques can be interfaced between different 
separation techniques and coupled with many different detection methods such as UV 
absorbance, laser-induced fluorescence or mass spectrometry to achieve full 
automation.10  Interfacing directly with MS has the additional requirements of having 
volatile buffer/solvent additives and little or no detergents.  Gradient LC can be used to 
concentrate the sample and improve the detection limits.  
 The interfacing of two different separation methods such as LC and CE has many 
restrictions.  First, the mobile phase used in the two separation modes must be 
compatible.  Because the two techniques have to be orthogonal, the solvents used for the 
two techniques have to be chosen carefully to compatible with all of the separations 
modes.  Second, excessive band broadening may be caused by the extra valves and loops 
used between columns.  This extra column band broadening will decrease the 
concentration of the low abundance proteins and raise the detection limits.  Third, it is 
required that the separation speed in the second dimension is much faster than that in the 
first dimension.  The total separation time is largely dependent on the speed of the second 
dimension separation, because each fraction must be separated by the second dimension.  
According to the third requirement, the comprehensive mode of a LC-LC system is more 
difficult to develop compared to LC-CE systems, because CE performs faster than LC.  
Coupling of LC with CE is complicated because there is generally a large difference in 
peak volume of the LC and the injection volume of the CE.  However, this discrepancy 
could be solved by employing a capillary HPLC column which uses a low flow rate.19   
1.3.3 Peak capacity 
As mentioned above, peak capacity is an important figure of merit for two-
dimensional separations.  It is the measurement of the maximum number of solutes that 
can be completely resolved between the inert peak and the last eluted peak.  To achieve 
the maximum peak capacity, the resolution between two adjacent peaks should be equal 
to one.  If the resolution between two adjacent peaks is smaller than one, the separation is 
not complete and the system is incomplete.  If the resolution is greater than one, the 
separation is complete but the system is wasteful.  Based on these conditions and the 
assumption that the plate number is the same for each solute, Giddings9 developed the 
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mathematical expressions for the peak capacity, nc, for isocratic/isothermal 
chromatography as in equation 1: 
                                   1/ln(4
1 ttNn nc += )                                         Equation 1 
Horvath and Lipsky21 further developed the peak capacity for gradient LC based on 
Giddings’ work.  They assume that all peaks have the same width: 






tNn nc                                            Equation 2 
In both equation 1 and 2, N is theoretical plate number, t1 and tn are the retention times of 
the first and the last peak.   
As indicated by equation 2, peak capacity is affected by the separation efficiency 
and the ratio of the elution time of the first and last peaks.  Since the elution time of the 
last peak is related to the nature of the last solute component, the main focus for 
optimizing peak capacity is maximizing the plate number.  There are many factors that 
affect the plate number, such as mobile phase velocity, column length, temperature, and 
the stationary phase.  Grushka22 gave a detailed discussion on how these different factors 
affect the peak capacity.   
However, the actual number of completely resolved components is always much 
smaller than the theoretical peak capacity.  It is shown that a random chromatogram will 
never contain more than 37% of its potential peak capacity and among these peaks only 
18% will be completely resolved23.  This discrepancy between the limited capabilities of 
one-dimensional separations and the complexity of real world samples motivates further 
development of multidimensional separations, due to the greatly enhanced resolving 
power they offer.  
In this work, the effective peak capacity of a saw-tooth gradient is explored.  The 
saw-tooth gradient can be used as the first dimension in a 2D separation when the 
separations are performed in series.  Measuring the peak capacity is important because 
the peak capacity of a 2D separation is the product of the peak capacity of each 
dimension.  Therefore, the main objective of this work is to determine if the peak 
capacity is high enough to be useful for comprehensive 2D proteomics separations.  The 
term effective peak capacity is used because the original definition of peak capacity 
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assumes use of a linear gradient.  The saw-tooth gradient investigated in this work 
includes positive, negative, and zero slope segments. 
1.4 Separation 
1.4.1 Background of liquid chromatography/high-performance liquid 
chromatography 
Chromatography is a physical separation technique in which the components are 
selectively distributed between two immiscible phases: a mobile phase and a stationary 
phase.  According to the mobile phase, chromatographic methods can be classified as: 
gas chromatography (GC), liquid chromatography (LC), or supercritical fluid 
chromatography (SFC).  The chromatography process is a repeated adsorption and 
desorption of analyte from the stationary phase as the analyte molecules move through 
the column.  The analytes are separated according to their differential solubility in the 
stationary phase and the mobile phase.24  
Many improvements in liquid chromatography are the result of improvements in 
in stationary phase materials.  Improvements in stationary phases provided smaller more 
uniform particles, and a new technique named high-performance liquid chromatography 
(HPLC) was established, providing higher separation efficiencies.  The free space 
between packing materials is decreased when smaller particles are used.  Therefore, the 
packing material had a much lower permeability so that it is necessary to use a pump to 
generate sufficient pressure to produce optimal flow rates.  HPLC has better resolving 
power and speed than the traditional liquid chromatography techniques.25   
A classification of the various modes of liquid chromatography includes: normal-
phase liquid chromatography, reverse-phase liquid chromatography, ion exchange 
chromatography, size exclusion chromatography and affinity chromatography.  Among 
these, reverse-phase liquid chromatography is the most common mode for the separations 
of compounds in chemical, biological, pharmaceutical and biomedical sciences.  The 
popularity lies in the following factors: 1) it has an excellent resolving power, 2) it is 
convenient to manipulate the chromatographic selectivity by changing mobile phase 
characteristics, 3) it has high recoveries, and 4) the reproducibility is great.26     




In reverse-phase liquid chromatography, the separation is carried out on a solid 
nonpolar stationary phase and a polar mobile phase.  The most commonly used nonpolar 
stationary phase is silica support bonded with hydrocarbon chains, such as C4, C8 and 
C18.  The mobile phase is typically a mixture of water with one or more organic solvents, 
such as acetonitrile, methanol, ethanol and isopropanol.  Acetonitrile is preferred in 
protein separation due to its low viscosity and low ultra-violet cut off (~190nm).  An ion-
pairing agent, such as acetic acid or heptafluorobutyric acid, is usually added in the 
mobile phase to reduce the ionic interactions with the silica surface.  The retention 
mechanism of reverse-phase LC is explained best by the solvophobic theory.27  This 
mechanism assumes that the stationary phase is a uniform layer of a non-polar ligand.  
When the solute binds to the stationary phase, the surface area of the solute exposed to 
the mobile phase is reduced.  This reduction in exposed surface area of solute to the 
solvent plays the greatest role in adsorption to stationary phase.  Therefore, the mobile 
phase composition has a greater influence on separation selectivity than the stationary 
phase in this mode of chromatography.27-31   
Separation of the protein mixture is dependent on the distribution coefficients of 
the individual species bound to the column.  The distribution coefficient (K), also known 
as the thermodynamic partition ratio, is the ratio of the concentration of the analyte in the 
stationary phase to its concentration in the mobile phase.  It depends only on temperature 
and the nature of the stationary and mobile phases. 
  K = Cs/Cm                                                           Equation 3 
Analytes with higher K values are bound more tightly to the column and will elute later 
in the separation. 
 The distribution coefficient can also be related to the capacity factor (k’), of the 
chromatographic system by the phase ratio (β). 
     K = k’ β                                                            Equation 4 
The phase ratio is characteristic for the column and relates the volume of the mobile 
phase to the volume of stationary phase. 
        β = Vm/Vs                                                           Equation 5 
The capacity factor is the ratio of the mass of analyte in the stationary phase to the mass 
of the analyte in the mobile phase. 
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       k’ = ms/mm                                                          Equation 6 
The capacity factor depends on the column characteristics (such as the column 
dimensions and phase ratio) and reflects the binding strength of a molecule to the 
stationary phase under specific experimental conditions. 
In reverse-phase HPLC, the analytes are introduced into the system in an aqueous 
solution and are eluted by the high organic content mobile phase.  The elution can be 
carried out either by isocratic or gradient conditions.  In isocratic elution, the 
concentration of organic solvent is constant, therefore, the k’ value for each analyte is 
constant.  In gradient separation, the organic solvent is increased with time, causing the k’ 
value for each analyte to decrease with time.  Gradient elution provides a solution for the 
general elution problem, which is the separation of a sample with very wide capacity 
factor in a reasonable time.  Compared to isocratic separation, the peaks will elute in less 
time with more uniform peak widths, improving the detection of latter eluting peaks.  
These improvements do, however, decrease the resolving power of the separation.  The k’ 
value decreases with the increasing solvent strength until the k’ is low enough that 
analyte desorbs from the column.  The relation of retention factor with the solvent 
strength can be represented by: 
                                               log k’ = - Sφ + log kw                                             Equation 7 
where φ is the volume fraction of organic solvent in mobile phase B, S is a constant, and 
kw is the value of k’ at zero organic solvent content (φ = 0)32.  The relationship of log k’ 
and φ is shown in Figure 1 by a small molecule and several big molecules such as 





 Figure 1.  Dependence of capacity factor k’ on mobile phase %B (φ) for a small 
molecule benzene and several peptides or proteins.  Adapted from reference 33.   
 
 
As shown in Figure 1, the small molecule benzene has small S value, therefore, a 
small change in φ  cause a slow change in k’.  It is also assesses that all isocratically 
eluted peaks are broad.  However, for large molecules, such as peptides and proteins, 
their S value is large and a very small change in φ will cause a rapid change in k’ causing 
them to elute in sharp peaks.  The greater S, the less partitioning there is after analyte 
desorbs which contributes to the formation of narrow peaks and improvement of 
sensitivity.  During the separation, different analytes progressively elute as the gradient 
moves through the reverse phase column, with the more hydrophobic analytes eluting 
later in the run.34   
1.4.2 Protein separations by reverse-phase high performance liquid 
chromatography (RP-HPLC) 
In reverse-phase liquid chromatography, proteins are adsorbed onto the 
hydrophobic surface of the column and eluted out at high organic content of the mobile 
phase.  The elution order is related to the hydrophobicity of the molecule — the more 
soluble a solute is in an organic solvent, the greater its retention time.  It has been 
reported that the binding of protein molecules to the hydrophobic surface in RP-HPLC 
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results in the denaturization of protein structures.35  The RP-HPLC separation process 
drives the protein molecule to unfold to expose its hydrophobic interior surface for better 
binding with the hydrophobic stationary phase.  The protein binds to the reverse-phase 
surface through the hydrophobic contact region. Proteins separate in reverse phase 
because the specific analyte-solvent interactions modulate solubility and give different 
binding strength for different proteins and peptides.  The percentage and type of organic 
modifier is the most important parameter in adjusting the retention of proteins because its 
inherently easier to adjust the mobile phase than repack the column.24   
 
 
Figure 2.  Schematic representation of a protein binding to a reverse-phase HPLC silica-
based sorbent.  The protein interacts with the immobilized hydrophobic ligands through 
the hydrophobic chromatographic contact region. 
 
1.4.2.1 The development of nonporous C18 reverse-phase liquid chromatography 
separation on proteins and peptides 
Researchers have struggled with finding adequate stationary phases for RP-HPLC 
separation of proteins, due to their large size and structural heterogeneity.  The column is 
an essential part of liquid chromatography and the development of the column packing 
material, type, size and shape has also gained substantial attention for a long time.  Silica 
is the most common solid support used in HPLC due to its wide availability in different 
shapes, sizes, and degrees of porosity.  It also can withstand a higher pressure than other 
material such as resins and soft gels.  Most importantly, the surface of the silica can be 
modified with different chemical bonding reactions.  With the advent of HPLC, smaller 
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and spherical porous or pellicular particles were developed to provide higher separation 
efficiencies.36   
When porous beads were introduced, the surface areas of the binding sites and the 
loading capacity of the column were greatly increased.  However, for protein separations, 
the use of porous particles tends to reduce separation efficiency and increase retention 
time.  Because proteins are large and approach pore size, it is difficult for proteins to 
diffuse in and out of pores and they can bind strongly in topographical defects that are 
very close to proteins in size.  Two methods can be used to solve this problem.  One is 
increase the pore size to have perfusion particles, and the other is to eliminate the pores.   
Column efficiency is measured by the theoretical plate height, H.  Minimizing H 
increases the number of theoretical plates and the separation efficiency.   The theoretical 
plate height was originally related to the linear flow rate (u) by the Van Deemter 
equation: 
H = A + B/u + Cu                                                          Equation 8 
In which A term is eddy diffusion, caused by the different travel paths of the solvent, B 
term is longitudinal diffusion, and C term is band broadening caused by stagnant mobile 
phase mass transfer and stationary phase mass transfer.  The detailed expression of each 
term is listed in Table 1.37  It is obvious from Table 1 that the decrease in particle size, dp, 
will decrease both terms A and C.  Therefore, the theoretical plate height is minimized by 
using small uniform particle.   
 
Table 1. Contribution of different band-broadening processes to column plate height H 
Process                                                                      Contributions to plate height 
Eddy diffusion (A-term)                                                           Cedp 
Mobile-phase mass transfer (A-term)                                      Cmdp2u/Dm 
Longitudinal diffusion (B-term)                                              CdDm/u 
Stagnant mobile-phase mass transfer (C-term)                       Csmdp2u/Dm 
Stationary-phase mass transfer (C-term)                                Csdf2u/Ds 
Note: Cd, Ce, Cm, Cs, Csm = plate height coefficients; dp = diameter of packing particle; df 
= thickness of stationary-phase layer; u = mobile-phase velocity.37  
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Several other modifications have been made to the Van Deemter equation to 
improve its validity and utility.  The Hawkes equation is one version that works well with 
packed column chromatography, because it places more emphasis on the Cm term that is 
usually negligible in the Van Deemter equation.38  This stationary phase mass transfer 
directly relates to the situation of a liquid stationary phase. 
The use of nonporous particles eliminates adsorption in the pores and eliminates 
the stagnant mobile phase mass transfer in term C of the Van Deemter equation.  Thus, 
the elimination of this mechanism of band broadening improves the separation efficiency 
and the protein recovery.  These advantages are especially pronounced with the use of 
smaller particles which is explained in the following paragraphs.39   
Snyder and Lommen compared the performance of several different columns that 
were packed with macroporous, porous, and nonporous particles for protein separations. 
The highest resolving powers were achieved for peptides and proteins with small 
nonporous particle packed columns.  However, the back pressure is increased due to the 
small size of nonporous particles.16, 40  
1.4.3 Saw-tooth gradient 
Generally, when a gradient is used by reverse-phase HPLC to separate a complex 
biomolecular sample such as whole proteins, the mixture will be separated into many 
unresolved peaks and only part of the samples will be collected for further analysis.   To 
achieve complete sample transfer between the first- and second-dimension, a novel saw-
tooth gradient was created in our lab.1  This saw-tooth gradient is composed of steps that 
include positive, negative and horizontal linear portions (as shown in Figure 3.).  The 
solvent strength change (Δφ) is the solvent difference between two maximum points of 






 The saw-tooth gradient was compared with a linear gradient and segmented 
gradient.  The difference between a saw-tooth gradient and a segmented gradient is that a 
negative slope portion is added after an increasing part in saw-tooth gradient.  It was 
determined that the resolving power of the saw-tooth gradient is comparable with that of 
the linear gradient and superior to the segmented gradient.  The results proved that the 
negative reduces the band broadening caused by the isocratic elution in the segmented 
gradient and improves the resolving power of the saw-tooth gradient.   
In this thesis, a novel saw-tooth gradient is connected in series as the first-
dimension for RP-HPLC separation of proteins prior to a second dimension separation. 
This novel saw-tooth gradient could separate the complex mixture into small subsets, and 
send the sample subsets to the second dimension for further separation.  The protein 
subsets can be separated by the second dimension, while an isocratic holding period, of 
arbitral length, holds the rest of the proteins on the column.  A low molecular weight 
human serum sample is used to determine the effective peak capacity of the saw-tooth 
gradient.  In this real sample, the more abundant peptides with greater peak widths will 
split in multiple fractions before the lower abundance proteins are.  Additionally, some 
peptides will elute near the end or peak of a saw-tooth gradient step and will split into 
multiple fractions before the peptides that elute in the middle of each step.  This peak 
splitting demonstrated in experimental data is that one single peptide or protein detected 
in more than one saw-tooth step.  Because the peak splitting will decrease the sensitivity 
of the detection, peak splitting should be minimized.  The extent of peak splitting and 
number of peptides identified is used to characterize the effective peak capacity as a 








 change (Δφ) 
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function of Δφ.  Mass spectra acquired during the holding period are used for relative 
quantitation of the amount of proteins that elute during the isocratic holding periods. 
1.5 Mass Spectrometry 
1.5.1 Electrospray ionization (ESI) 
Electrospray ionization (ESI) is a soft ionization technique that is applicable to 
charged compounds in liquid matrices.  The majority of ions produced by electrospray, 
for large biomolecules, are multiply charged, which greatly extends the mass range of the 
instrument as the mass spectrometers measure the m/z (mass-to-charge) ratio of an ion.  
They are only multiply charged if the have a lot of basic functional groups (for low pH at 
positive ion mode) and a lot of acidic functional groups (for high pH at negative ion 
mode).  In ESI, ions are generated by the drying of charged droplets over micro second 
time scales, which is relatively long at the molecular level.  The large energy required for 
ionization is applied slowly, avoiding fragmentation.  Thermally labile molecules may be 
ionized without fragmentation which is the characterization of the soft ionization.  Thus, 
ESI has become an essential tool for characterization of large biomolecules, since its 
introduction by Fenn.41    
 A simplified representation of the ESI process is shown in Figure 4.  A potential 
difference, typically in the 1-4kV range, is applied between the spray tip of the capillary 
and a counter electrode that is separated 1-2mm.  This high voltage produces an 
electrostatic field to disperse the solution from the spray tip into a fine mist of charged 
droplets.  ESI is initiated when columbic repulsions exceed surface tension.  The charged 
droplets enter the heated capillary and repeated cycles of solvent evaporation and droplet 
fission eventually generates bare ions in the gas phase.  Then the ions enter the mass 





Figure 4.  Schematic of the mechanism of electrospray ionization 
 
1.5.2 Fourier transform ion cyclotron resonance mass spectrometry (FT-ICRMS) 
Fourier transform mass spectrometers are well known for their excellent mass 
accuracy and resolution.  Their potential is fully realized when combined with external 
ionization technique such as electrospray ionization.  The principle of the technique is 
based on ion cyclotron resonance where the ions are analyzed and detected in a cubical or 
cylindrical cell.  This cell mainly contains four plates: two excitation plates and two 
detection plates.  A magnetic field is applied to the cell which cause the ions move 
perpendicular to its direction.  Initially, the orbit radii of ions in the FT-ICR are too small 
to be detected.  A radio frequency potential pulse is applied to the two excitation plates at 
the resonant frequency of the ions, which excites the ions increasing the radius of their 
orbit.  Ions of different m/z values orbit at different frequencies, and this orbital motion is 
called the cyclotron motion.  The cyclotron frequency is related to the mass-to-charge 




=                                                     Equation 9 
 
f  is cyclotron frequency (hertz, Hz), z is the net number of electronic charges on the ion, 
e is the charge per electron (coulombs, C), B is magnetic field strength (tesla, T) and m is 
the mass of an ion.  Ions of lower m/z will have higher cyclotron frequencies than ions of 
higher m/z.  When these ions pass the detection plates, they induce a change in the plates 
that is measured electronically, providing non-destructive detection.  The induced change 
on the detection plates is measured as a time-domain free-ion decay signal.  The time 
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dependent ion curves represent the detection of all the ions at the same time with 
different cyclotron frequencies.  The Fourier transform converts this time-domain data 
into a frequency-domain signal.  A mass spectrum is generated by relating the frequency 
is related to m/z by equation 9.43  The combination of Fourier transform with ICR MS 
also improves the signal-to-noise ratio (S/N) of the analysis.  The signal is degraded 
when the pressure and the number of the ions inside the ICR cell increase.  The reason is 
that the cyclotron frequencies of the trapped ions are shifted because of the increasing of 
pressure and the population of the ions.  These shifts will affect the measured mass 
values.  Therefore, FT-ICRMS is best interfaced with an external ionization source, such 
as ESI, to maintain the low pressure in the ICR cell. 
 Mass accuracy is the measurement of the closeness of the observed m/z to the true 
value.  It is very important when measuring complex samples in which many components 
could have the similar m/z values.  Among the modern commercial mass spectrometers, 
FT-ICR has mass accuracy to 1ppm or lower where others are in the order of tens of parts 
per million over a specific mass range. 
Resolution is also very important for resolving closely spaced signals, especially a 
complex mixture.  From equation 10, it is obvious that resolution (R) is proportional to 
the magnetic field strength B and observation time T but inverse to m/z.42 
m
kzBTR ≤                                                        Equation 10 
Resolution can be improved by increasing the magnetic field strength or the observation 
time.  Since increasing the strength of the magnetic field is expensive, the observation 
time is always increased to improve the resolution. 
The low molecular weight human serum sample used in this work is a complex 
sample is composed mainly of peptides with at least thousands of different sequences.  
Therefore, the high resolving power and mass accuracy of FT-ICR mass spectrometer 
will aid in determining the number of peptides in each saw-tooth step and which peptides 
are found in multiple fractions.  The peptides are normally multiply charged and the high 
resolving power of the FT-ICR is needed to resolve the isotopic peaks and determine 
their charge state.  This peptide-like signature is used to distinguish the proteins and 
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peptides in stead of identifying them by sequence matching.  The mass spectra are 
deconvoluted to determine their accurate mass from the numerous peaks present. 
2. Experimental 
2.1 Model proteins separation on analytical-HPLC 
 In this section, all the experiments are carried out on an Agilent 1100 series 
analytical-HPLC (Agilent Technologies Inc., Delaware, OH) equipped with a 20 µL 
manual injector, a binary pump, a column heating chamber and a diode array detector 
(DAD) with a 5 µL flow cell.  The column used is a 1.5 µm nonporous silica C18 column 
(NPS ODS-I, 33 × 3.0 mm, Eprogen Inc., Darien, IL).  Mobile phase A contains 5% 
HPLC-grade acetonitrile, 0.1% (v/v) glacial acetic acid, 0.05% heptafluorobutyric acid 
(HFBA), and 95% deionized water.  Mobile phase B contains 70% acetonitrile, 0.1% 
(v/v) acetic acid, 0.05% HFBA and 30% deionized water.  All the chemicals are 
purchased from Fisher Scientific (Fair Lawn, NJ) without further processing.  The 
Chemstation software is used to set the flow rate to 0.2 mL/min, the column heating 
temperature at 60°C, and the DAD wavelength to 215 nm. 
Two proteins are used as model proteins for the peak splitting study on the 
analytical-HPLC system and each is obtained in lyophilized form from Sigma-Aldrich 
Co. (St. Louis, MO) and used without further purification.  These two standard proteins,  
ribonuclease A (RNase A, from Bovine pancreas) and carbonic anhydrase I (CA1, from 
human Erythrocytes), represent a low molecular weight protein (RNase A, 16461 Da) and 
a high molecular weight protein (CA1, 28870 Da) in the low molecular weight (≤30 kDa) 
human serum proteins.  Stock solutions for each protein are prepared separately at a 
concentration of 50 µM in mobile phase A and stored at 0°C until used.  A mixture of the 
two proteins for protein peak splitting and recovery studies are prepared by diluting both 
protein concentrations to 1.0 µM with mobile phase A.  The solvent strength change is 
decreased from 5.0%, to 1.0%, 0.1% to check the peak splitting.  The saw-tooth gradients 
used for peak splitting studies of standard proteins on analytical-HPLC are summarized 
in Figure 5.  The gradient setup details are listed in Appendix 1. Blank run is tested 




























Figure 5.  Programmed saw-tooth gradients used in peak splitting test by two model 
proteins on the analytical-HPLC.  The linear gradient for the protein recovery test is also 
presented for comparison.  The solvent strength changes (Δφ) for method standard-1, 
standard-2, and standard-3 are 5.0%, 1.0% and 0.1% respectively. 
 
Protein recovery test is carried out to provide supporting evidence for the peak 
splitting test that is justified by the changing of protein peak areas.  The linear gradient 
used in protein recovery experiments increases the mobile phase B from 0% to 100% in 
40 min, plateaues at 100% for 5 min, and decreases to 0% in 5 min (as shown in Figure 5 
and Table 2).  Each sample run is conducted after a water blank run to check the stability 
of the baseline. 
 
Table 2.  Linear gradient used in protein recovery test on the analytical-HPLC 








2.2 Anthracene separation on analytical-HPLC 
In this section, all the experiments are carried out on an Agilent 1100 series 
analytical-HPLC.  The instrument set up and column used are all the same as for the 
model proteins except that the DAD wavelength is 225 nm. 
Anthracene is purchased from Sigma-Aldrich Co. (St. Louis, MO) and used 
without further purification.  A stock solution of 50 ppm anthracene dissolved in 
acetonitrile is used.  The solvent strength change is decreased from 5.0%, to 1.0%, 0.1% 
to check the peak splitting.  The saw-tooth gradient shapes maintain the same as that used 
for model proteins except that the start point for the first saw-tooth step is adjusted for 
anthracene to save time.  The linear gradient used to provide supporting information is 
the same as for the model proteins.  The saw-tooth gradients used for peak splitting are 
summarized in Figure 6.  The gradient setup details are listed in Appendix 2. Blank run is 























Figure 6.  Programmed saw-tooth gradients used in peak splitting test by anthracene on 
the analytical-HPLC.  The solvent strength changes (Δφ) for method anthracene-1, 




2.3 Gradient shape and column test on nano-HPLC 
 All the following experiments are carried out on an Agilent 1100 nano-HPLC 
(Agilent Technologies, Delaware, OH) equipped with a nano-pump and a variable 
wavelength detector (VWD) with a 35 nL flow cell.  The experimental conditions are 
listed as follows: flow rates are 0.7 µL/min for gradient shape test and 0.5 µL/min for 
protein recovery test on three different columns, column temperature is 60°C, and 
absorbance is monitored at 215 nm.  The column temperature is controlled by a heating 
matt (Model 03125-10 with extension adapter 03122-71) which is set with a temperature 
controller (standard model: 89000-00) and monitored by a thermocouple probe (Type T, 
08113-22).  All the heating equipments are purchased from Cole-Parmer Instrument Co. 
(Vernon Hills, IL).  Mobile phase A contains 0.05% heptafluorobutyric acid, 0.1% acetic 
acid, 5% acetonitrile and 95% deionized water; mobile phase B is 0.05% 
heptafluorobutyric acid, 0.1% acetic acid, 70% acetonitrile and 30% deionized water.   
2.3.1 Gradient shape test by different saw-tooth gradients 
 The four saw-tooth gradients used for the nano-HPLC-FTICR MS analysis are 
monitored on the nano-HPLC to get the actual gradient shape.   
To measure the maximum peak capacity, the solvent strength of the saw-tooth 
gradient is decreased to the minimum to find out if the protein will split into more than 
one saw-tooth steps.  The solvent strength change (Δφ) of the saw-tooth gradients is 
decreased from 1.0%, 0.5%, 0.2% to 0.1% (minimum value allowed by the ChemStation 
software) with the 26.0-27.0% mobile phase B range (Figure 7, detail set up in Appendix 
3).  The actual gradient shape of those different saw-tooth gradients are tested on the 
nano-HPLC by a nonporous C18 capillary column (1.5 µm, 25 mm × 200 µm, beads 
purchased from Eprogen, Inc.).  The capillary column used in the nano-HPLC for 
gradient shape experiments is called test capillary column and is obtained in a similar 
process as the separation column.  This test capillary column has the same dimension and 
packing material as the separation capillary column except the spray tip is replaced by an 
inline-microfilter with a 1.0 µm stainless steel microscreen (void volume is about 109 
nL) (Upchurch Scientific Inc., Oak Harbor, WA)  to hold the nonporous beads.  All the 




























Figure 7. Programmed saw-tooth gradients of four different Δφ for LMW (≤30 kDa) 
human serum sample peak splitting studies on the nano-HPLC-FTICR MS.  The solvent 
strength changes (Δφ) for method serum-1, serum-2, serum-3, and serum-4 are 1.0%, 
0.5%, 0.2%, and 0.1% respectively. 
 
2.3.2 Comparison of protein recovery on three different types of columns 
 Protein recovery is compared on three different columns.  The three columns are: 
Zorbax 300SB-C18 (3.5 µm, 300 Å, 150 mm × 75 µm, Agilent Technologies, Delaware, 
OH), porous C8 column (5 µm Monitor 100 Å-Spherical silica beads, 40 mm × 200 µm, 
beads purchased from Column Engineering, Inc., Ontario, CA), nonporous C18 column 
(1.5 µm, 70 mm × 200 µm, beads purchased from Eprogen Inc., Darien, IL).  The 
experimental conditions maintain the same for all three columns.  Sample is 10.0 µM 
carbonic anhydrase I in mobile phase A and injection volume is 1.0 µL.  Linear gradient 
begins at 0% B at time 0, increases to 100%B by 40 min, remains at 100% for 10 min, 




2.4 LMW (≤30 kDa) human serum separation on nano-HPLC-FTICR 
MS 
2.4.1 Nano-HPLC-FTICR MS analysis of LMW (≤30 kDa) human serum  
 The LMW (≤30 kDa) human serum sample is prepared by ultrafiltration as 
described in the Harper et al protocol.11  Preparation of the 30 kDa centrifugal filter 
membranes is performed according to the manufacture’s specifications.  One milliliter of 
human serum (From clotted human male whole blood, Sigma-Aldrich, St. Louis, MO) is 
processed by first dividing the sample into 200 µL aliquots, then diluting with 120 µL of 
deionized water and 20% (v/v) acetonitrile.  Proteins are denatured at 40°C for 15 min; 
then, centrifuged at 9700 rpm for 10 min to remove any precipitated material that could 
clog the filters.  Supernatants are then added to the prepared centrifugal filters and spun at 
3760 rpm for 120 min.  The filtrates are lyophilized and stored at -80°C until use.  The 
LMW (≤30 kDa) human serum samples are prepared by dissolving one vial of the stock 
in 20 µL deionized water which is 0.155mg/mL as measured in section 3.4.2.  Then the 
sample is introduced directly into the separation column by using a pressure vessel 
(pressure is ~30 bar).  One microliter of sample is injected for each run and the amount of 
the injection is monitored by a 5 µL micro-pipette. 
The instruments used are an Agilent 1100 nano-HPLC pump which can generate 
flow rate from 100 nL to 4.0 µL and a hybrid linear trap quadrupole 7-Tesla Fourier 
transform ion cyclotron resonance (FTICR) mass spectrometer (Thermo Finnigan, San 
Jose, CA).  The nano-HPLC conditions are listed as follows: flow rate is 0.7 µL/min and 
the column temperature is 60°C.     
 Prior to analysis of samples, LTQ-FTICR MS is tuned and calibrated by a direct 
infusion of a solution containing 1pmol/µL Angiotensin I and Somatostatin in 50% 
methanol/0.1 M acetic acid.  Both peptides are purchased from Sigma Aldrich (St. Louis, 
MO) without further purification.  The experiment parameters used in direct infusion are: 
spray voltage is 2.5 kV; capillary temperature is 200°C; sample flow rate is 0.5 µL/min 
controlled by syringe injector.  The spray tip of 5-µm inner diameter is made from a 360 
× 100 µm fused silica capillary by a pre-setting program of a laser puller (Model P-2000, 
Sutter Instrument Co., Novato, CA). 
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 For analysis of low molecular weight (≤30 kDa) human serum proteins, the 
lyophilized sample is dissolved in 20 µL of deionized water and introduced directly onto 
the separation column by using a pressure vessel at about 30 bar.  The amount of the 
injection is 1 µL as monitored by a micro-pipette.  Data is collected with the FTMS over 
a scan range of 300-2000 m/z using profile mode by the Tune Plus software at a selected 
resolution of 200,000 and scan time of 1000 ms.  Spray voltagee sets at 2.5kV with 
positive ESI mode.  Heated capillary temperature sets at 200°C.   
The separation capillary column used in the nano-HPLC-FTICR MS is packed in 
a capillary with a pulled tip.  In the pulling process, a 360 × 200 µm fused silica capillary 
(~15 cm long) (Polymicro Technologies, L.L.C., Phoenix, AZ) is obtained and the 
polyimide coating is removed over a small section (~1 cm) in the middle to make a 
window.  Next, the spray tip is pulled with a laser puller (Model P-2000, Sutter 
Instrument Co., Novato, CA) to make a 20 µm inner diameter tip.44  During packing, 5 
µm porous silica C18 beads (Monitor, 300 Å, Column Engineering, Inc., Ontario, CA) is 
loaded with the pressure vessel for 1-2 seconds at 1 bar to form a holding frit (~1 mm 
long).  Then, the 1.5 µm nonporous C18 beads are loaded into the column with the 
pressure vessel at 30 bar until it reaches a length of about 2.5 cm long.  After packing, the 
column is conditioned by first injecting 1pmol Angiotensin I (Sigma-Aldrich, St. Louis, 
MO) with the pressure vessel and then running a 30 min linear gradient with the HPLC 
pump.  The conditioned columns are stored in mobile phase A until use.  The schematic 








  Maximum effective peak capacity of the saw-tooth gradient is explored by 
decreasing the solvent strength change from 1.0%, 0.5% and 0.2% to 0.1% (as shown in 
Figure 7.).  A long linear gradient is also designed to compare with the saw-tooth 
gradient of 0.1% Δφ.  The effective separation range for the long linear gradient from 
26.0%-27.0% mobile phase B is designed to contain only the effective separation time 
(30.4 min, the isocratic part is subtracted) of the 0.1% Δφ saw-tooth gradient.  The long 
linear gradient increases from 0% to 20% in 10 min, from 20% to 26% in 10 min, from 
26% to 27% in 30.4 min, from27.0% to 100% in 4.6 min (as shown in Table 3).  The first 
20 min of the long linear gradient is designed to decrease the overall gradient time. 
 
Table 3. The detailed setup of long linear gradient for LMW (≤ 30kDa) human serum 
sample on the nano-HPLC-FTICR MS. 
Long linear gradient 








Xtract in Qual Browser (Xcalibur version is 2.0) is used to deconvolute all spectra 
acquired.  The spectrum Xtract settings are: Generate Masses Mode is M (whole 
molecular weight), resolution at 400 m/z is 200000, S/N threshold is 2 and the mass 
range is 300.0-2000.0.   
2.4.2 LMW (≤30 kDa) human serum mass measurement by protein assay 
 The concentration of the low molecular weight (≤30 kDa) human serum sample is 
measured by the Bio-Rad Protein Assay.  This method is based on a dye-binding assay 
which will result in a color change when different concentrations of protein bind to dyes 
in the assay.  450 mL Dye reagent concentrate and lyophilized bovine serum albumin are 
purchased from Bio-Rad for this experiment.  Dye reagent concentrate is diluted by 
adding 25 mL concentrated dye reagent to 100 mL deionized water (ratio is 1:4).  Then 
the diluted dye reagent is filtered by 0.22 µm pore size Durapore membrane filter paper 
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(Millipore, Billerica, MA).  Lyophilized bovine serum albumin is dissolved in 20 mL 
deionized water to make a bulk concentration of 1.44 mg/mL.  Four standard bovine 
serum albumin solutions are made from the stock: 0.2, 0.4, 0.6 and 0.8 mg/mL.  5.0 mL 
of diluted dye reagent is added to 100 µL of the above standard solutions and each 
solution is mixed well.  The lyophilized LMW (≤30 kDa) human serum sample is 
dissolved in 10 µL deionized water and five vials of the same samples are added together 
to get 50 µL sample for measurement in VU-Vis absorbance sepctrophotometer.  2.5 mL 
diluted dye reagent is added into the 50 µL sample.  All the standards and the sample are 
incubated at room temperature for 10 minutes and the absorbance is measured at 595 nm.  
The measurement is carried out on a Smart Spec 3000 Spectrophotometer (Bio-Rad, 
Hercules, CA).  The concentration of the low molecular weight (≤30 kDa) human serum 
sample is obtained from the standard curve by bovine serum albumin. 
3. Results and Discussion 
3.1 Model proteins separation on analytical-HPLC  
3.1.1 Peak splitting and protein recovery test of two model proteins 
 Each saw-tooth gradient step is characterized by a net change in solvent strength 
change (Δφ) as shown in Figure 3.  If each saw-tooth gradient step is treated as a single 
fraction, decreasing the step size increases the number of fractions that can be collected 
and the effective peak capacity.  To achieve the best limits of detection in the MS, the 
average peak width should be matched with the Δφ.  Thus, there is an optimum Δφ value 
that maximizes the peak capacity and number of proteins or peptides detected while 
minimizing the peak splitting.   
The objective of this work is to determine this optimum Δφ value which will be 
used in the determination of the effective peak capacity.  This optimum Δφ value will be 
used in place of the separation efficiency in the calculation of the peak capacity.  To 
determine if peak splitting could be observed directly, two protein standards, 
ribonuclease A and carbonic anhydrase I, are separated at Δφ values of 5.0%, 1.0%, and 
0.1% as shown in Figure 9.  No attempt is made to align the center of the Δφ of the saw-
tooth gradient step with the median Δφ value of the peak.  Thus, the median φ value of 
elution of the sample band may or may not be aligned with the positive slope segment of 
 
 27
the saw-tooth step.  Figure 9 (B) shows no peak splitting for RNase A.  Figure 9 (B) 
shows three peaks for the second standard, CA1.  As observed in Figure 9 (A), CA1 has a 
small peak at the tail of the main peak which is also present with the linear gradient.  The 
small peak is resolved better in all of the three saw-tooth gradients and is caused by the 
partially denatured structures of CA1 when binding with the hydrophobic surface of the 
column.45,46  In the linear gradient, a primary peak and an additionally smaller peak are 
clearly detected.  The presence of multiple isoforms for carbonic anhydrase 1 has been 
noted in the literature.47  In the saw-tooth gradient, three peaks are detected, and it is 


























































































5.0% Δφ 1.0% Δφ 0.1% Δφ
 
Figure 9.  Chromatograms of model proteins produced by linear and saw-tooth gradients 
at various Δφ values.  (A) Separation of RNase A and CA1 using a linear gradient; the 
retention time of RNase is16.3min and the rentention time of CA1 is 25.5 min.  (B) The 
peak shape obtained with saw-tooth gradient for solvent strength changes (Δφ) of 5.0%, 
1.0% and 0.1%.  The slope of the linear gradient is the same as all the positive segment of 
the saw-tooth gradients. 
 
 29
Although peak splitting is not definitely observed, it is possible that some of the 
sample may not elute in a detectable manner.  For instance, a portion of the sample may 
“bleed off” the column in a broad undetectable peak.  Therefore, the peak areas of the 
standards at a number of Δφ values are compared with the peak area obtained with the 
linear gradient.  The peak area obtained with the linear gradient is assumed to represent 
complete elution.  In addition to incomplete protein recovery, other deleterious effects of 
the saw-tooth gradient adversely affect peak width and symmetry.  Further peak splitting 
effect is explored on the main peak of RNase and CA1 by comparing the peak area, peak 
width and asymmetry obtained from the saw-tooth gradients with the same parameters 
from the linear gradient.  Peak asymmetry is measured at the 10% peak height as B/A, 
where A is the distance from peak front to peak maximum and B is the distance from 
peak maximum to peak end (Figure 10).34  As can be seen from Figure 10, peaks of good 
symmetry has a B/A value that equals 1.  Peak tailing gives B/A value greater than 1 and 





Figure 10.  Illustration for measurement of peak asymmetry.  Peak asymmetry is 
measured at the 10% peak height as B/A, where A is the distance from peak front to peak 
maximum and B is the distance from peak maximum to peak end. 
 
The average values of four experimental results are compared by T-test as in Table 4.  
There is no significant difference between the saw-tooth and the linear gradient for peak 
area and peak width for both proteins.  However, the asymmetries of the three saw-tooth 
gradients are all significantly greater than the asymmetry of the linear gradient for RNase 
A.  Although the asymmetry T-test for CA1 is not significant for all three saw-tooth 
gradients, it does show that the asymmetry value of CA1 is higher than that of the linear 
gradient.  When designing the experiments, the linear gradient and the three saw-tooth 
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gradients are carried out in the same day under the same experimental conditions with 
varying orders of data acquisition to rule out the systematical error.  Therefore, the tailing 
of the protein peak in three saw-tooth gradients is due to the specific design of the saw-
tooth gradient.  Under the linear gradient, the peak tail elutes under high solvent strength 
and the peak is focused, which helps provide symmetric peaks.  For a saw-tooth gradient, 
the situation is reverse compared with what happens by a linear gradient.  The peak front 
has stronger organic content than the peak tail, which increases peak tailing.     
 
Table 4.  Comparison of model protein peaks produced by linear and saw-tooth gradients 
at various Δφ values.  T-tests are carried out on peak area, peak width and asymmetry of 
each protein to compare the average value of the saw-tooth gradients with the linear 
gradient.  
(A) Comparison of peak areas 
Saw-tooth  Linear gradient 
Protein 
Δφ Average peak area (mAU·s) Std dev 
Average peak 
area (mAU·s) Std dev 
t-test (P-value)
5.0% 221 12 0.93 
1.0% 233 17 0.28 RNase A 
0.1% 235 12 
222 3 
0.23 
5.0% 478 15 0.32 
1.0% 508 23 0.74 CA1 




(B) Comparison of peak widths 
Saw-tooth  Linear gradient 
Protein 
Δφ Average peak width (min) Std dev 
Average peak 
width (min) Std dev 
t-test (P-value)
5.0% 0.28 0.008 0.84 
1.0% 0.29 0.028 0.91 RNase A 
0.1% 0.28 0.013 
0.29 0.018 
0.81 
5.0% 0.29 0.008 0.22 
1.0% 0.30 0.005 0.68 CA1 




(C) Comparison of peak asymmetries 
Saw-tooth  Linear gradient 
Protein 
Δφ Average peak asymmetry Std dev 
Average peak 
asymmetry Std dev 
t-test (P-value)
5.0% 3.5 1.4 0.02* 
1.0% 4.0 1.1 0.008* RNase A 
0.1% 3.5 0.95 
1.1 0.17 
0.02* 
5.0% 3.4 0.25 0.18 
1.0% 3.3 0.49 0.20 CA1 
0.1% 3.3 0.53 
2.6 0.96 
0.22 
         ∗: Significant 
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3.2 Anthracene separation on analytical-HPLC 
  Previous experiments show no peak splitting for proteins.  It is suspect that 
proteins has a very large S value (as indicated in Figure 1) which makes capacity factor (k’) 
changing rapidly with a small change of organic content in solvent B (φ) and results in no 
peak splitting for proteins.  However, small molecules such as anthracene has a small S 
value which makes k’ changing slowly with small change of φ.  Therefore, small molecules 
are susceptible to split into more than one saw-tooth steps.  Anthracene with molecular 
weight of 178.32 is chosen to represent a small molecule to see if peak splitting can be 
observed. 
  The chromatograms of the peak splitting and peak recovery for anthracene are 
presented in Figure 11 with programmed gradients superimposed.  Compared with linear 
gradient, no peak splitting is observed for anthracene by three different saw-tooth 
gradients.  However, it is noticed that the peak area from three saw-tooth gradients are 
much smaller than the peak area from the linear gradient.  T-tests are carried out on peak 
area and peak width for each anthracene peak to compare the average value of the saw-
tooth gradients with those from the linear gradients.  The results are summarized in Table 
5.  As can be seen from Table 5, the peak areas of anthracene by three saw-tooth gradients 
are all significantly smaller than the peak area by the linear gradient, which indicates 
anthracene is not fully recovered in the observable peaks.  The peak area of anthracene 
decreases with the decreasing of the Δφ of the saw-tooth gradient.  The peak width of 
anthracene shows the same trend as that of peak area.  Both data indicate that peak splitting 
occurs when saw-tooth gradients are employed.  The reduced peak area of anthracene 
further confirms the experimental results of the slow change of the capacity factor with 
organic content in solvent B for small molecules. 
  Therefore, the saw-tooth gradient is well suited for large biomolecules such as 
proteins that elute in narrow Δφ ranges.  Because proteins elute in narrow Δφ ranges, a 

































chromatogram-1 chromatogram-2 chromatogram-3 chromatogram-4
gradient-1 gradient-2 gradient-3 gradient-4
5.0% ∆φ 1.0% ∆φ 0.1% ∆φ
 
Figure 11.  Chromatograms of anthracene produced by linear and saw-tooth gradients at 
various Δφ values with the programmed gradients are superimposed.  The solvent strength 
changes (Δφ) for three saw-tooth gradients gradient-2, gradient-3 and gradient-4 are 5.0%, 
1.0% and 0.1% respectively.  The decreased peak area of the lower molecular weight 
anthracene is significantly different from the observed results with the protein standards 














Table 5.  Comparison of anthracene peaks produced by linear and saw-tooth gradients at 
various Δφ values.  T-tests are carried out on peak area and peak width to compare the 
average value of the saw-tooth gradients with that of the linear gradient.  
 
(A) Comparison of peak areas 
Saw-tooth  Linear gradient 
Protein 
Δφ Average peak area (mAU·s) Std dev 
Average peak 
area (mAU·s) Std dev 
t-test (P-value)
5.0% 1349 33 <0.001∗ 
1.0% 1265 64 <0.001∗ Anthracene 




(B) Comparison of peak widths 
Saw-tooth  Linear gradient 
Protein 
Δφ Average peak width (min) Std dev 
Average peak 
width (min) Std dev 
t-test (P-value)
5.0% 0.76 0.015 <0.001∗ 
1.0% 0.78 0.013 <0.001∗ Anthracene 
0.1% 0.81 0.013 
0.51 0.002 
<0.001∗ 
      ∗: Significant 
 
 
3.3 Gradient shape and column test on nano-HPLC  
3.3.1 Gradient shape test by different saw-tooth gradients 
 An important characteristic of the saw-tooth gradient is that the features created 
by the changes in sign of the slope or the gradient “teeth” are susceptible to rounding in 
which the sharp features in solvent strength are lost.  This is a main concern when the 
saw-tooth gradient is used with a capillary column and low low flow rates.  Gradient 
rounding is related to the dwell volume and dispersion or loss of the desired shape.  
Dispersion and gradient rounding can be also caused by the same processes that give rise 
to band dispersion in transfer capillaries or tubes, including Taylor dispersion caused by 
the parabolic profile of pressure driven flow and longitudinal diffusion.  The dwell 
volume is defined as the volume between the point at which solvents are mixed and the 
beginning of the column.48  The volume of the mixer plays a major role in the amount of 
gradient rounding.  For most effective retention of the initial gradient shape, it is 
important to minimize the dwell volume between the pumps and the column inlet.  To 
monitor the gradient shape no injection is made and the gradient shape is followed by 
monitoring the change in solvent absorbance from the changes in acetonitrile 
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concentration.  Thus, the actual gradient shape could be monitored at the detector, and 
compared with the programmed gradient.  Both the programmed gradient and gradient 
shape measured by the absorbance detector are shown with the total ion chromatograms 
(TIC) in Figure 12.   As shown in Figure 12 (A-D), the actual saw-tooth gradient steps 
still provide an incremental increase with the Δφ decreases from 1.0% to 0.5%, 0.2% and 





























































































































































Figure 12 (A - B). Total ion chromatograms of two saw-tooth gradients (Δφ is 1.0% 
and 0.5%) with the gradients superimposed.  In each TIC, the fractions that are used for 
total protein count and protein overlapping are marked. (A) TIC obtained by saw-tooth 
gradient serum-1: Δφ = 1.0%, fraction 3 used; (B) TIC obtained by saw-tooth gradient 



































__ Total ion chromatogram







































































__ Total ion chromatogram






































Figure 12 (C - D). Total ion chromatograms of two saw-tooth gradients (Δφ is 0.2% 
and 0.1%) with the gradients superimposed.  In each TIC, the fractions that are used for 
total protein count and protein overlapping are marked. (C) TIC obtained by saw-tooth 
gradient serum-3: Δφ = 0.2%, fraction 4, 5, 6 and 7 used; (D) TIC obtained by saw-tooth 




 The degree of gradient rounding is related to VM/VG, where VM is the volume 
from mixer to column head, and VG is the gradient volume.33  A smaller VM/VG causes 
reduced gradient rounding.  Generally, when VM/VG >0.1, the gradient is significantly 
distorted.49  For the Agilent 1100 nano-HPLC used here, a built-in splitter, electronic 
flow control (EFC) which contains an electromagnetic proportional valve and a flow 
sensor, are used to deliver the nano-scale flow rate to the column while dumping a very 




Figure 13.  Schematic of connections from mixing point of Agilent 1100 nano pump to 
the separation column.50  V0 is volume from mixing point to the tubing after the filter.  V1 
is the volume from EMPV to the flow sensor, V2 is the connecting tubing from the flow 
sensor to a zero dead volume Tee connector, and V3 is the empty tubing before the 
packing of the separation column. 
 
The flow rate before the splitter is 2.5mL/min and the total volume (V0) is 398 µL 
which make the delivery time very short (9.6 seconds) during this section,50  producing a 
negligible amount of distortion before the EFC.  The effective mixing volume includes 
the volume after EMPV and contains the volume from the EMPV to the column inlet.50  
VM can be obtained by the following equation 11:49 
 
                                                  VM2 = V12 + V22 + V32                                  Equation 11 
 
Where V1 is the volume from EMPV to the flow sensor, V2 is the connecting tubing from 
the flow sensor to a zero dead volume Tee connector, and V3 is the empty tubing before 
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the packing of the separation column.  In this experiment, V1 is 0.3µL50, V2 is 0.18µL 
(360mm×25µm capillary tubing), and V3 is 3.77µL (120mm×200µm), yielding VM of a 
3.8µL.  Clearly, VM is dominanted by the empty tubing before the packing in the column.  
The effective gradient time (tG) for the saw-tooth gradient with 0.1%Δφ is 70 min and the 
volumetric flow rate (F) is 0.7µL/min.  VG (49 µL) can be calculated from the following 
equation 12, which is 49µL. 
 
                                                       VG = tG × F                                              Equation 12 
 
The gradient rounding of VM/VG is 0.08.  The saw-tooth gradient with 0.1%Δφ is still in 
allowable range without severe rounding by the nano-HPLC as shown by the actual 
gradient shape in Figure 12 (D).  
A more detailed numerical analysis of the saw-tooth gradient rounding for  
0.1%Δφ is presented in Table 6.  It is noticed that the pump delivery is stabilized after the 
first few saw-tooth steps following the long linear start.  The absorbance differences 
between two adjacent peak points are calculated from the third “teeth” where the pump 
delivery is stabilized.  The average value of absorbance is 0.016 mAU with std. dev. of 
0.005 and relative standard deviation of 31%.   Although the gradient rounding is 
substantial for Δφ= 0.1%, as shown in Figure 12 (D), there is a consistent increase in Δφ 
with each saw-tooth step once the gradient stabilizes, as shown in Table 6.  The large 
relative standard deviation indicates that the pump is working near the limit of the 
minimum Δφ for which it can produce consistent increases in solvent strength.  The 
maximum peak capacity experiment with serum in the range of 26.0%-27.0% solvent B 









Table 6. The absorbance maxima for each tooth or step of the saw-tooth gradient for a 
0.1% Δφ.  The average and standard deviation of the absorbance difference between two 
adjacent peak points is calculated. 
 
serum-4 gradient (Δφ = 0.1%) 
B (%) Absorbance (mAU) 
Absorbance difference between peak points 
(mAU) 
26.1 4.963 — 
26.2 4.975 0.012 
26.3 4.981 0.006 
26.4 4.999 0.018 
26.5 5.018 0.019 
26.6 5.042 0.024 
26.7 5.060 0.018 
26.8 5.072 0.012 
26.9 5.087 0.015 
27.0 5.110 0.023 
 Average: 0.016 mAU 
 Std dev: 0.005                   RSD: 31% 
 
Two other important limitations of the HPLC system for the saw-tooth gradient is 
the number of points that can be set and the precision to which the gradient can be set.  
The maximum number of points that can be set in the Chemstation software is 50, 
limiting the maximum number of peaks of saw-tooth steps to 15.  The maximum settable 
precision of the gradient is one-tenth of a percent, which limits the minimum Δφ to 0.1%.   
3.3.2 Comparison of protein recovery on three different types of columns 
Theoretically, columns packed with nonporous beads provide better separation 
efficiency for protein separation than porous beads.  The small nonporous beads decrease 
eddy diffusion and improve the separation efficiency.  In order to verify that the nonporous 
beads perform better than the porous beads with low molecular weight serum sample, 
columns packed with nonporous and porous beads are compared.  Figure 14 presents the 
results of the protein recovery tests on three reverse phase columns with different types of 
beads or packing material.  The retention times of CA1 on three columns are around 70 min 
as shown in Figure 14.  It is observed that the retention time of the CA1 is far behind the 
end point of the gradient.  This discrepancy is caused by the extra volume from the 
autosampler added between nano-pump and the column.  However, there is a huge 
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difference between the protein recoveries between nonporous bead packed column and the 
porous ones.  The protein peak intensity on the nonporous bead column is more than 10 
fold of that of porous columns.  The higher protein recovery of the nonporous C18 column 
indicates it is the best among the three columns.  This result is consistent with the previous 
observations that nonporous beads provide greater separation efficiency for proteins by 



































Figure 14. Protein recovery on three RP-HPLC columns packed with different types of 
beads.  Nonporous beads packed column has the highest protein recovery rate among 
three types of columns.   The dead time is about 5 min. 
 
3.4 LMW (≤30 kDa) human serum separation on nano-HPLC-FTICR 
MS 
3.4.1 Nano-HPLC-FTICR MS analysis of LMW (≤30 kDa) human serum  
Here, the effective peak capacity with minimum sample splitting is evaluated 
using the low molecular weight fraction of human serum.  The sample is prepared by 
ultrafiltration of the whole human serum.  Human serum contains on the order of ten 
thousand proteins with a dynamic range of protein concentration that spans nine orders of 
magnitude, making it a complex sample with components having a wide range of 
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concentrations.  The LMW (≤30 kDa) human serum contains many low molecular weight 
components, especially peptides.  The peptides are not identified by sequence 
determination; instead, the molecular weight is used to distinguish among different 
peptides. 
Initially, it is anticipated that the number of components that are split between 
multiple fractions will increase as the Δφ value decreases, and an optimum value will be 
observed after which excessive peak splitting will diminish the ability to detect additional 
proteins.  The effects of decreasing the magnitude of the Δφ value on the peak splitting 
and the total number of proteins identified are investigated.  As the Δφ value decreases, it 
is expected that peak splitting will increase and that peak splitting will eventually cause a 
decrease in the number of proteins identified.  It was hypothesized that Δφ values 
significantly narrower than the average peak width will divide the components in 
multiple fractions, decreasing the S/N in the MS.  Because the endpoints of each saw-
tooth gradient step are arbitrarily set, components that elute at these Δφ values are 
expected to split into two fractions.  Broader peaks are expected to split into multiple 
fractions before narrower peaks split.  Thus some peak splitting is anticipated.  In this 
real sample, differences in peak width are caused by differences in relative abundance 
and by differences in the absorptive properties of the peptides.  The objective of many 
proteomic experiments is to identify as many proteins as possible from a complex sample 
and the most difficult proteins and peptides to detect are the low abundance proteins and 
peptides.  Therefore, the effective peak capacity should be characterized with signals of 
lower intensity and the Δφ value at which these peaks split corresponds to the peak width 
term in the calculation of the peak capacity.  It should be noted that while splitting of the 
higher intensity signals increases as the Δφ value decreases, the number of protein 
identification increases over the range tested.  It should be noted that the LMW (≤30 
kDa) human serum sample provides a realistic and stringent test because peptide have 
lower molecular weight values than that of proteins. 
Separations are performed for Δφ values of 1.0%, 0.5%, 0.2%, and 0.1%.  The 
total ion chromatogram of the eluted proteins and the programmed gradients are shown in 
Figure 12.  Due to the instrumental limitation of a maximum of 50 data points, a range of 
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26.0% to 27.0% solvent B was focused on.  A capillary column is used for the separation 
to increase the separation efficiency and to use a format that is consistent with standard 
proteomic methods.  An electrospray interface is used to inject the peptides directly into 
the MS, and the peptide masses are measured at high mass accuracy (<2 ppm).  The 
peptide signals are identified using an automated deconvolution routine and the 
identifications are checked manually.  Manual checking of the identifications returned by 
the deconvolution routine revealed many signals that could not be validated due to low 
signal to noise and a lack of the characteristic isotopic peaks.  When the deconvoluted 
masses are compared within the triplicate runs it is found that the signals that could not 
be manually validated did not appear in the multiple runs.  Upon comparing the triplicate 
runs, only the signals that are common to all three of the chromatograms are considered 
real and are reported in Figure 16 and Table 7.  This approach provided a means to select 
reliable matches in a rapid and repeatable manner.  The TICs are shown in Figure 12 (A-
D) indicate that groups of peptides clearly elute in each step of the saw-tooth gradient and 
appear as well defined peaks.  After elution of the peak associated with each saw-tooth 
gradient step, the peptides are largely held on the column during the holding period. As 
the Δφ of each saw-tooth gradient step is reduced, the area of the corresponding peak 
decreases, because the amount of protein eluted with each step decreases. 
Using linear gradient as a standard, the total protein and the protein splitting 
numbers by four saw-tooth gradients are compared in the solvent strength range of 
26.0%-27.0% mobile phase B (Figure 16 and Table 7).  For a saw-tooth gradient with 
1.0% Δφ, only one fraction (fraction 3 in Figure 12 (A)) is contained in this range, 
therefore, only total protein numbers are counted for this saw-tooth gradient.  For saw-
tooth gradient with 0.5% Δφ, two fractions (fraction 4 and 5 in Figure 12 (B)) are used for 
total protein and overlapping protein numbers counting.  There are four fractions for saw-
tooth gradient with 0.2% Δφ (fraction 4 to7 in Figure 12 (C)) and ten fractions for saw-
tooth gradient with 0.1% Δφ (fraction 4 to13 in Figure 12 (D)).  
It can be seen that the number of peptides split in more than one fractions 
increases from 5 to 28 (or 24) as the Δφ value decreases from 0.5%, and 0.2% to 0.1%.  
This increased splitting is not advantageous, but the total number of peptides increases 
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from 30 to 59 and 24 to 67 as the Δφ value decreases (as shown in Figure 16 and Table 
7).   
For saw-tooth gradients with a 0.1% Δφ, the mobile phase B only increases 1.0%, 
one may suspect that if the result of this saw-tooth gradient is the same as a similar linear 
gradient, then it has no sense to waste such a long time (66.4 min include isocratic part) 
to get the same result as a linear gradient.  The saw-tooth gradient provides unique 
capabilities.  However, the saw-tooth gradient could adversely affect the S/N of the peak.  
The linear gradient is used as the standard to compare the peaks from the saw-tooth 
gradient to determine if the peaks are adversely affected.  For saw-tooth gradient, some 
gradient character is retained compare to the similar linear gradient.  The extra time 
includes the negative slope part and the isocratic part.  Since the isocratic part acts as a 
holding period to carry out a second dimensional separation and the length can be set 
arbitrarily, it is not counted as the effective separation time.  The effective separation 
time only contains the positive slope part and the negative slope part which is 30.4 min 
for saw-tooth gradient with a 0.1% Δφ.  The total protein count range for the long linear 
gradient is also 26.0%-27.0% of mobile phase B which is 28.2-58.6min after adding the 


















































Figure 15. Total ion chromatogram of the long linear gradient with the gradient 
superimposed.  The fractions that are used for total protein count and protein overlapping 
are marked, total Δφ = 1.0%, 26.0%-27.0% solvent B range is used.  
 
The total peptide signals detected using the long linear gradient is also presented 
in Figure 16.  The total peptide signals detected by the 0.1% Δφ saw-tooth gradient (59 
and 67, as indicated in Table 7) is larger than that of the long linear gradient (54 and 58, 
as indicated in Table 7).  A loss in the peak capacity is not observed when compared with 
a long linear gradient.  In fact, the number of peptide signals detected during the steps of 
the saw-tooth gradient was greater for the saw-tooth gradient than the corresponding long 
linear gradient.   
Because the primary objective of proteomic experiments is protein or peptide 
identification, the saw-tooth gradient with a Δφ of 0.1% provides the best overall 
performance.  Unfortunately, instrumental limitations prevent the programming of 
gradient steps smaller than 0.1%, prohibiting the analysis of smaller steps.  However, 
previous experiments indicate that 0.1% is near the instrumental limit of the HPLC nano 
pump.  This instrumental limitation could be overcome by narrowing range of solvents A 
and B.  Therefore, over a range of 0 to 100% solvent B, 1000 fractions could be collected 
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for a saw-tooth gradient with a 0.1%Δφ,  However, the proteins and peptides do not elute 
over the entire range which makes the actual fractions or groups of proteins that can be 






























total peptide signal detected-1
total peptdie signal detected for  long linear gradient-1
peptide splittings-2
total peptide signal detected-2
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Figure 16. Total peptide signals detected and protein splitting numbers of four saw-tooth 
gradients in the 26.0%-27.0% range of solvent B.  Each series corresponds to peptides 
signals common to all three runs of a triplicate set.  Data of two triplicate sets are 
presented.  Total protein of the long linear gradient at the same separation time range 











Table 7.  Detailed results of total peptide signals detected and protein splitting numbers 
of four saw-tooth gradients and a long linear gradient in the 26.0%-27.0% range of 
solvent B.  Numerical data plotted in Figure 16. 
Group 1 result — in black  
Gradient type Saw-tooth Linear 
∆Ф 1.0% 0.5% 0.2% 0.1% 1.0% 
Proteins in 1 fraction 25 25 24 31 54 
Split in 2 fractions — 5 14 17 — 
Split in 3 fractions — — 4 6 — 
Split in 4 fractions — — 1 1 — 
Split in 5 fractions — — 0 2 — 
Split in 6 fractions — — — 2 — 
Split in 7 fractions — — — 0 — 
Split in 8 fractions — — — 0 — 
Split in 9 fractions — — — 0 — 
Split in 10 fractions — — — 0 — 
total splittings 0 5 19 28 — 
total proteins 25 30 43 59 54 
 
Group 2 result — in grey 
Gradient type Saw-tooth Linear 
∆Ф 1.0% 0.5% 0.2% 0.1% 1.0% 
Proteins in 1 fraction 21 19 29 43 58 
Split in 2 fractions — 5 17 17 — 
Split in 3 fractions — — 2 3 — 
Split in 4 fractions — — 1 2 — 
Split in 5 fractions — — 0 0 — 
Split in 6 fractions — — — 0 — 
Split in 7 fractions — — — 1 — 
Split in 8 fractions — — — 1 — 
Split in 9 fractions — — — 0 — 
Split in 10 fractions — — — 0 — 
total splittings 0 5 20 24 — 
total proteins 21 24 49 67 58 
 
 
A surprising result is that the total number of peptide signals detected with the 
saw-tooth gradient is slightly more than the number of peptide signals detected with the 
long linear gradient.  Further comparisons are needed to better understand this 
improvement in the number of peptide signals detected.  As presented by Figure 17, a 
saw-tooth gradient with 5.0% Δφ is compared with two linear gradients in the 45.0-65.0% 
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solvent B range.  Linear gradient-1 is increased from 0 to 100% solvent B in 40min, 
producing the same 2.5%/min slope as the saw-tooth gradient and only takes 8min to 
bring solvent B from 45.0-65.0%.  Linear gradient-2 is increased from 0 to 45% solvent 
B in 18min, 45% to 65% in 20min, and 65% to 100% in 2 min.  It has the same effective 
separation time (20min from 45% to 65% solvent B) as the saw-tooth gradient.  Linear 
gradient-1 has 2.5%/min slope, which is the same slope as the positive slope segment of 
the 5.0% Δφ saw-tooth gradient.  Linear gradient-2 has the same total time and solvent 
strength change as the 5.0% Δφ saw-tooth gradient and has a slope of 1.0%/min.  The 
total time for the 5.0% Δφ saw-tooth gradient is calculated for the positive and negative 
slope segments only without the isocratic portion.  The isocratic portion is not included 
because the length of the holding period is arbitrary.  Compared with linear gradient-1, 
the saw-tooth gradient has the same slope as linear gradient-1 but a longer separation 
time which increase the peak capacity.  As to linear gradient-2, the saw-tooth gradient has 
the same separation time but a steeper slope which could improve the sensitivity.  
Therefore, the saw-tooth gradient has a better resolving power and signal to noise ratio 
compared to the corresponding linear gradients which explain the results of the LMW 
(≤30 kDa) human serum on the series saw-tooth gradients.  With the decreasing of Δφ, 
the separation time of saw-tooth gradient is elongated with a steeper slope as compared 
with corresponding linear gradients to provide better resolution and sensitivity.  These 
improvements lead to the  detection of more peptide and protein signals in the sample.     
As presented previously, proteins have large S values and only can observe 
splitting with saw-tooth gradient.  While peptides of small molecular weight have small S 
value and making them more susceptible to peak splitting.  The masses of the signals 






























Figure 17. Theoretical comparison of the saw-tooth gradient with two linear gradients in 
the 45.0-65.0% solvent B range.  Saw-tooth gradient has a 2.5%/min slope with 20 min 
total effective separation time.  Linear gradient-1 has the same slope as the saw-tooth 




Another concern is whether proteins or peptides elute isocratically during the 
holding period.  The mass spectra of the 0.1% solvent strength saw-tooth gradient from 
Figure 12 (D) are analyzed to determine the extent of protein loss in the isocratic part.  
Fraction 4, fraction 5 and the isocratic holding segment between fraction 4 and 5 are 
explored.  Their mass spectra are presented in Figure 18.  After deconvolution of the 
spectra in the isocratic segment, the peptide masses are compared with the fractions right 
before and after it.  It is observed that proteins found in this holding period are either 
already appeared in its previous or appear in later fractions.  Four representative peak 
spectra are presented: m/z: 772.57; m/z: 719.80; m/z: 847.57; and m/z: 822.68.  The 
monoisotopic masses for each m/z after deconvolution are also presented in Figure 18.  
The spectra show some elution of the peptides during the isocratic portion of the gradient, 
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at levels that are roughly between 10-20% of the peak intensity during the saw-tooth 
elution.  This level of isocratic elution is not significant and a second dimension 































































































































Figure 18.  Mass spectra of fractions when Δφ = 0.1% from Figure 12(D).  Peptides 
signals detected in fraction 4 are labeled with “∗” while proteins identified in fraction 5 
are labeled with “#”.  A) Mass spectrum of fraction 4; B) Mass spectrum of isocratic part 
between fractions 4 and 5; C) Mass spectrum of fraction 5.  Note changes in the intensity 
scale.  D) Four representative isotopic distributions of peptides from isocratic segment 
are listed with their monoisotopic masses: (1) m/z: 772.57; (2) m/z: 719.80; (3) m/z: 
847.57; (4) m/z: 822.68. 
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3.4.2 Measure of the total protein content in the LMW (≤30 kDa) human serum 
fraction 
 To determine the total protein content in the human serum sample, the Bio-Rad 
protein assay colorimetric method is used.  A calibration curve is made by measuring the 
absorbance of different concentrations of the standard, BSA, by the Smart Spec 3000 
Spectrophotometer.  As shown in Table 8, the absorbance is plotted as a function of 
concentration in Figure 19.  The absorbance of the LMW (≤30 kDa) human serum 
fraction is measured for three samples, and the concentration of the sample is obtained 
using the calibration curve.  The average concentration of the sample is 0.309 mg/mL 
(Table 9).  Because the total proteins concentration is very low for the LMW (≤30 kDa) 
human serum to be measured by protein assay, the measured concentration of the LMW 
(≤30 kDa) human serum sample dissolved in 10 µL is appropriate for the measurement.  
The concentration of the LMW (≤30 kDa) human serum sample for LC-FTMS 
experiments is dissolved in 20 µL to avoid long cleaning time of the less hydrophobic 
peptides and proteins.  The total peptides and proteins concentration measured for the 
sample is 0.155 mg/mL.  Since only 1 µL sample is injected into the capillary column, 
the mass of proteins for nano-LC-FTMS analysis is 0.155 µg. 
 
Table 8. Measurement of absorbance on different concentration of standard BSA 
Concentration of BSA (mg/mL) 0.2 0.4 0.6 0.8 




























Figure 19. Standard curve of BSA together with the concentration of LMW ((≤30kDa) 
human serum determined by this standard curve. 
 
Table 9. The absorbance and corresponding concentration of the LMW (≤30kDa) human 
serum fraction.  The average concentration is obtained from the three sample 
measurements. 
Sample # 1 2 3 
Absorbance, y 0.378 0.358 0.354 















The performance of saw-tooth gradient is explored by two model proteins and a 
real proteomic sample.  Peak splitting is studied by two model proteins on analytical-
HPLC.  No peak splitting is observed for both proteins by decreasing the solvent strength 
change from 5.0%, 1.0%, to 0.1%.  However, the peak tailing is more severe for the saw-
tooth gradient than for the linear gradient.  A small molecular weight anthracene is used 
for peak splitting by saw-tooth gradients with Δφ decreases from 5.0% to 1.0% and 0.1%.  
The obvious peak splitting explained the theoretical prediction that saw-tooth gradient 
works great for large molecules such as proteins.  The protein recovery is compared 
among three different columns: porous C8, porous C18 and nonporous C18.  Nonporous 
C18 column has the best protein recovery among three columns.  Peak capacity of the 
saw-tooth gradient is explored by a real proteomic sample on nano-HPLC-FTICR MS by 
decreasing the solvent strength change from 1.0%, 0.5%, 0.2%, to the minimum of 0.1% 
in the 26.0%-27.0% solvent B range.  The total peptide signals detected and peptide 
splitting number are both increased with the decreasing solvent strength change.  
However, the total peptide signals detected number increases more rapidly than the 
peptide split numbers.  A loss in the peak capacity is not observed when compared with a 
long linear gradient.  Moreover, protein loss is little in the isocratic part of the saw-tooth 
gradient.  Consider the primary objective of the proteomic experiment is protein or total 
peptide signals detected, the saw-tooth gradient with a Δφ of 0.1% provides the best 
overall performance.  With the saw-tooth gradient, a slightly greater number of peptide 
signal is detected, allbut at a cost of time.  However, it does provide a holding period that 
can be used for a downstream operation, such as a second dimension of separation.  The 
sample injection amount is substantially decreased by the capillary column which is also 
important for the analysis of biology samples.  Overall, the saw-tooth gradient provides a 
promising first-dimension separation technique for peptides and proteins without a 
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Detail program of different saw-tooth gradients used in this thesis 
1. Programmed saw-tooth gradients used in peak splitting test by two model proteins 
on the analytical-HPLC. 
 
Standard-1 Standard-2 Standard-3 
Δφ=5.0% Δφ=1.0% Δφ=0.1% 
t (min) B (%) t (min) B (%) t (min) B (%) 
0.00 0.0 0.00 0.0 0.00 0.0 
14.00 35.0 15.20 38.0 15.80 39.5 
15.00 30.0 16.20 33.0 16.80 34.5 
19.00 30.0 20.20 33.0 20.80 34.5 
23.00 40.0 22.60 39.0 22.84 39.6 
24.00 35.0 23.60 34.0 23.84 34.6 
28.00 35.0 27.60 34.0 27.84 34.6 
32.00 45.0 30.00 40.0 29.84 39.7 
33.00 40.0 31.00 35.0 30.84 34.7 
37.00 40.0 35.00 35.0 34.84 34.7 
43.00 55.0 44.20 58.0 44.88 59.8 
44.00 50.0 45.20 53.0 45.88 54.8 
48.00 50.0 49.20 53.0 49.88 54.8 
52.00 60.0 51.60 59.0 51.92 59.9 
53.00 55.0 52.60 54.0 52.92 54.9 
57.00 55.0 56.60 54.0 56.92 54.9 
61.00 65.0 59.00 60.0 58.96 60.0 
62.00 60.0 60.00 55.0 59.96 55.0 
66.00 60.0 64.00 55.0 63.96 55.0 
70.00 100.0 67.00 100.0 65.00 100.0 
 
 
2. Programmed saw-tooth gradients used in peak splitting test by anthracene on the 
analytical-HPLC. 
Anthracene-1 Anthracene-2 Anthracene-3 
Δφ=5.0% Δφ=1.0% Δφ=0.1% 
t (min) B (%) t (min) B (%) t (min) B (%) 
0.00 0.0 0.00 0.0 0.00 0.0 
10.00 25.0 11.60 29.0 11.96 29.9 
11.00 20.0 12.60 24.0 12.96 24.9 
15.00 20.0 16.60 24.0 16.96 24.9 
19.00 30.0 19.00 30.0 19.00 30.0 
20.00 25.0 20.00 25.0 20.00 25.0 
24.00 25.0 24.00 25.0 24.00 25.0 
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28.00 35.0 26.40 31.0 26.04 30.1 
29.00 30.0 27.40 26.0 27.04 25.1 
33.00 30.0 31.40 26.0 31.04 25.1 
34.00 100.0 33.00 100.0 33.00 100.0 
 
 
3. Detailed setup of programmed four saw-tooth gradients for LMW (≤30kDa) 
human serum sample peak splitting studies on the nano-HPLC-FTICR MS.  Total 
protein count and protein overlapping are compared in the 26.0%-27.0% solvent 
strength of mobile phase B. 
 
serum-1 serum-2 serum-3 serum-4 
Δφ = 1.0% Δφ = 0.5% Δφ = 0.2% Δφ = 0.1% 
t (min) B (%) t (min) B (%) t (min) B (%) t (min) B (%) 
0.00 0.0 0.00 0.0 0.00 0.0 0.00 0.0 
10.00 25.0 10.00 25.0 10.00 25.0 10.00 25.0 
11.00 20.0 11.00 20.0 11.00 20.0 11.00 20.0 
15.00 20.0 15.00 20.0 15.00 20.0 15.00 20.0 
17.40 26.0 17.20 25.5 17.20 25.5 17.20 25.5 
18.40 21.0 18.20 20.5 18.20 20.5 18.20 20.5 
22.40 21.0 22.20 20.5 22.20 20.5 22.20 20.5 
24.80 27.0 24.40 26.0 24.40 26.0 24.40 26.0 
25.80 22.0 25.40 21.0 25.40 21.0 25.40 21.0 
29.80 22.0 29.40 21.0 29.40 21.0 29.40 21.0 
32.20 28.0 31.60 26.5 31.50 26.3 31.44 26.1 
33.20 23.0 32.60 21.5 32.50 21.3 32.44 21.1 
37.20 23.0 36.60 21.5 36.50 21.3 36.44 21.1 
39.60 29.0 38.80 27.0 38.60 26.5 38.48 26.2 
40.60 24.0 39.80 22.0 39.60 21.5 39.48 21.2 
44.60 24.0 43.80 22.0 43.60 21.5 43.48 21.2 
47.00 30.0 46.00 27.5 45.70 26.8 45.52 26.3 
48.00 25.0 47.00 22.5 46.70 21.8 46.52 21.3 
52.00 25.0 51.00 22.5 50.70 21.8 50.52 21.3 
54.40 31.0 53.20 28.0 52.80 27.0 52.56 26.4 
55.40 26.0 54.20 23.0 53.80 22.0 53.56 21.4 
59.40 26.0 58.20 23.0 57.80 22.0 57.56 21.4 
61.80 32.0 60.20 28.5 59.90 27.3 59.60 26.5 
62.80 27.0 61.20 23.5 60.90 22.3 60.60 21.5 
66.80 27.0 65.20 23.5 64.90 22.3 64.60 21.5 
69.20 33.0 67.40 29.0 67.00 27.5 66.64 26.6 
70.20 28.0 68.40 24.0 68.00 22.5 67.64 21.6 





76.60 34.0 74.60 29.5 74.10 27.8 73.68 26.7 
77.60 29.0 75.60 24.5 75.10 22.8 74.68 21.7 
81.60 29.0 79.60 24.5 79.10 22.8 78.68 21.7 
84.00 35.0 81.80 30.0 81.20 28.0 80.72 26.8 
85.00 30.0 82.80 25.0 82.20 23.0 81.72 21.8 
89.00 30.0 86.80 25.0 86.20 23.0 85.72 21.8 
93.00 40.0 90.80 35.0 90.20 33.0 87.76 26.9 
94.00 35.0 91.80 30.0 91.20 28.0 88.76 21.9 
98.00 35.0 95.80 30.0 95.20 28.0 92.76 21.9 
102.00 45.0 99.80 40.0 101.20 43.0 94.80 27.0 
103.00 40.0 100.80 35.0 102.20 38.0 95.80 22.0 
107.00 40.0 104.80 35.0 106.20 38.0 99.80 22.0 
113.00 55.0 110.80 50.0 112.20 53.0 105.80 37.0 
114.00 50.0 111.80 45.0 113.20 48.0 106.80 32.0 
118.00 50.0 115.80 45.0 117.20 48.0 110.80 32.0 
124.00 65.0 121.80 60.0 123.20 63.0 116.80 47.0 
125.00 60.0 122.80 55.0 124.20 58.0 117.80 42.0 
129.00 60.0 126.80 55.0 128.20 58.0 121.80 42.0 
135.00 100.0 130.00 100.0 130.00 100.0 125.00 100.0 
 
